The role of interleukin-2 in the treatment of cancer patients by J. WagstaffThe role of interleukin-2 in the treatment of cancer patients by J. Wagstaff

The role of interleukin-2 in the treatment of cancer patients

EditorJ. Wagstaff

Paperback | October 29, 2012

Pricing and Purchase Info

$159.25 online 
$167.95 list price save 5%
Earn 796 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is designed to provide the clinical oncologist wishing to use interleukin-2 with a basic background concerning the biology of the agent, a discussion concerning practical aspects, of its clinical use including management of toxicity and an overview of the clinical results together with a description of how this internesting cytokine might be developed in the future.
Title:The role of interleukin-2 in the treatment of cancer patientsFormat:PaperbackDimensions:201 pages, 9.45 × 6.3 × 0 inPublished:October 29, 2012Publisher:Springer NetherlandsLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401047693

ISBN - 13:9789401047692


Table of Contents

Preface. 1. Introduction; J. Wagstaff. 2. Interleukin-2 as a single Agent: Dose, Scheduling and Optimum Immunomodularity Dose; L.M. Jost, R.A. Stahel. 3. Interleukin-2 and Lymphokine Activated Killer (LAK) Cells; S. Negrier, T.P. Philip. 4. Interleukin-2 Toxicity: Mechanisms and Management; J.W. Baars. 5. Interleukin-2: Biology and Immunology; G. Parmiani, C. Gambacorti-Passerini. 6. Interleukin-2 and Tumour Eradication by Cytotoxic T Lymphocytes; C.J.M. Melief, W.M. Kast. 7. Combination Treatment with Interleukin-2 and Chemotherapeutic Agents; A. von Rohr, N. Thatcher. 8. Interleukin-2, Lymphocytes and Monoclonal Antibodies; R.L.H. Bolhuis, G. Stoter. 9. Interleukin-2 and Other Cytokines; J. Atzpodien. 10. Future Prospects for Interleukin-2 Therapy; C.R. Franks, P.R. Palmer. Index.